United States· US:31722-842_3de3bb2e-97bf-4a59-e063-6294a90a7744
ELTROMBOPAG
A other systemic hemostatics product containing eltrombopag, registered in United States by Camber Pharmaceuticals, Inc.. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Eltrombopag is registered in 3 of 19 countries.
Countries holding a registration under ATC B02BX (other systemic hemostatics), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Eltrombopag · ATC B02BX
3 / 19 countries
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ELTROMBOPAG
- Manufacturer
- Camber Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- B02BX
- ATC class
- Other systemic hemostatics
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc11317228423030 TABLET, FILM COATED in 1 BOTTLE (31722-842-30)
Regulatory notes
Same medicine, other countries
Eltrombopag in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsEltrombopag Abdi 25 mg filmomhulde tablettenAbdi Farma GmbH
- SwitzerlandEltrombopag Accord
- SpainELTROMBOPAG ACCORD 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- SwedenEltrombopag Accord 25 mg Filmdragerad tablettAccord Healthcare S.L.U.
- PolandEltrombopag AccordAccord Healthcare S.L.U.
- NorwayEltrombopag AccordAccord Healthcare S.L.U.
- IrelandEltrombopag Krka 25 mg film-coated tabletsKRKA, d.d., Novo mesto
- United KingdomEltrombopag 25mg tabletsPerennial Pharma Ltd
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Elrevolan, Eltrombopag +pharma
- Belgium · Eltrombopag Krka
- Bulgaria · Eltrombopag Pharmascience, Eltrombopag Pharmdedict
- Cyprus · Eltrombopag Msn, Eltrombopag Sandoz
- Czechia · Eltrombopag Abdi, Eltrombopag Krka
- Germany · Eltrombopag 1 A Pharma, Eltrombopag Abdi
- Denmark · Eltrombopag Glenmark, Eltrombopag Krka
- Estonia · Eltrombopag Krka, Eltrombopag Msn
- Spain · Eltrombgopa Glenmark, Eltrombopag Aurovitas Spain
- Finland · Eltrombopag Avansor, Eltrombopag Krka
- France · Eltrombopag Biogaran, Eltrombopag Eg
- United Kingdom (Northern Ireland) · Eltrombopag Abdi, Eltrombopag Accord
- Greece · Eltrombopag Anabiosis, Eltrombopag Faran
- Croatia · Eltrombopag Alpha-Medical, Eltrombopag Msn
- Hungary · Elrevolan, Eltrombopag Elpen
- Ireland · Eltrombopag Clonmel, Eltrombopag Krka
- Iceland · Eltrombopag Accord, Eltrombopag Coripharma
- Italy · Elrevolan, Eltrombopag Abdi
- Liechtenstein · Eltrombopag Accord, Eltrombopag Viatris
- Lithuania · Eltrombopag Krka, Eltrombopag Msn
- Latvia · Eltrombopag Krka, Eltrombopag Olpha
- Malta · Eltrombopag Aspen, Eltrombopag Clonmel
- Netherlands · Eltrombopag Abdi, Eltrombopag Amarox
- Norway · Eltrombopag Accord, Eltrombopag Glenmark
- Poland · Eltrombopag Glenmark, Eltrombopag Krka
- Portugal · Eltrombopag Bluepharma, Eltrombopag Cipla
- Romania · Eltrombopag Dr. Reddy’s, Eltrombopag Msn
- Sweden · Eltrombopag Anabiosis, Eltrombopag Avansor
- Slovenia · Eltrombopag Krka, Eltrombopag Msn
- Slovakia · Eltrombopag Glenmark, Eltrombopag Krka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dcb374d0-e550-4bc2-940d-b1c7e558d2d4 GET /v1/drugs/dcb374d0-e550-4bc2-940d-b1c7e558d2d4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "4U07F515LG",
"rxcui": "735651",
"inchikey": "PLILLUUXAVKBPY-SBIAVEDLSA-N",
"display_name": "ELTROMBOPAG OLAMINE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"spl_meta": {
"4af8f855-f710-e96f-e063-6294a90abb46": {
"match": "brand_token",
"title": "ELTROMBOPAG OLAMINE (ELTROMBOPAG) TABLET, FILM COATED [AVKARE]",
"spl_version": "2",
"published_date": "2026-05-22"
}
},
"productid": "31722-842_3de3bb2e-97bf-4a59-e063-6294a90a7744",
"productndc": "31722-842",
"dosage_form": "TABLET, FILM COATED",
"orange_book": {
"appl_no": "206788",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 12.5MG ACID",
"product_no": "001",
"approval_date": "Jan 17, 2025"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 25MG ACID",
"product_no": "002",
"approval_date": "Jan 17, 2025"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 50MG ACID",
"product_no": "003",
"approval_date": "Jan 17, 2025"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 75MG ACID",
"product_no": "004",
"approval_date": "Jan 17, 2025"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "ELTROMBOPAG OLAMINE",
"proprietary_name": "ELTROMBOPAG",
"active_ingred_unit": "mg/1",
"application_number": "ANDA206788",
"marketing_category": "ANDA",
"nonproprietary_name": "ELTROMBOPAG",
"start_marketing_date": "20250513",
"active_numerator_strength": "25"
}See everything about eltrombopag.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.